期刊文献+

晚期胃癌并发下肢深静脉血栓患者的护理 被引量:2

下载PDF
导出
摘要 总结30例晚期胃癌并发下肢深静脉血栓患者的护理体会。护理重点为根据经股静脉置入滤器和经颈静脉置入滤器途径的不同给予相对应的护理,尿激酶导管溶栓注意检测凝血功能,妥善固定导管并保持导管通畅,视溶栓情况做好拔管护理,同时重视出血、肺栓塞等并发症的观察与护理,加强出院指导。经治疗与护理,30例患者腘静脉以上静脉内血栓全部溶解,住院12~16d后出院,随防6~18个月,无血栓复发。
出处 《护理与康复》 2016年第8期767-769,共3页 Journal of Nursing and Rehabilitation
  • 相关文献

参考文献9

  • 1徐霖.下肢深静脉血栓形成[M].武汉:湖北科技出版社,2005:396-401.
  • 2Noble S, Pasi J. Epidemiology and pathophysiology of cancer- associated thrombosis [-JT. Br J Cancer, 2010, 102 (Suppll) $2 - $9.
  • 3曹玲玲,段朝霞,张婷,袁瑞兰,王刚阳.恶性肿瘤与血栓形成研究进展[J].现代生物医学进展,2016,16(11):2187-2190. 被引量:17
  • 4Bernstein R, Haim N, Brenner B, et al. Venous sonography for the diagnosis of asymptomatic deep vein thrombosis in patients with cancer undergoing chemotherapy[J]. J Ultrasound Meal, 2004,23(5) 7655-658.
  • 5Ghuman DK, Cohen AJ, The spectrum of hypercoagulable states in minority patients with unexplained thrombosis[-J. Blood (ASH Annual Meeting Abstracts), 2005,106 : 4111.
  • 6Musallam KM, Dahdaleh FS, Shamseddine AI, et al. Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapyEJ. Thromb Res, 2009,123 (5) : 679- 686.
  • 7赵晶,姜达.恶性肿瘤高凝状态及其干预[J].癌症进展,2013,11(1):48-52. 被引量:39
  • 8Mori A, Ibata M, Mashiko S, et al. Long-term administration of alow-moleeular-weight heparin contributed to successful treatment in a patient with primary mediastinal large B-cell lym- phoma and venous thromboembolismFJ. Clin Appl Thromb Hem- ost, 2008,14 (4) 468- 471.
  • 9Cronin- Fenton DP, Sondergaard F, Pedersen LA, et al. Hospi tallsationfor venous thromboembolism in cancer patients and thegeneral population a population- based cohort study in Denmark, 1997- 2006 [-J. Br J Cancer, 2010, 103 ( 7 ) : 947 - 953.

二级参考文献60

  • 1陈芳,宁琴,孙汉英,苏凯,严伟明,习东,罗小平,刘文励.恶性肿瘤组织中人纤维介素的表达及作用[J].华中科技大学学报(医学版),2006,35(4):444-448. 被引量:8
  • 2Farge D,Durant C,Villiers S. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients[J].Thrombosis Research,2010,(Suppl 2):S108-S116.
  • 3VM Konala,J Sprandio,DH Henry. A case of lung cancer and hypercoagulability,complicated by suspected heparininduced thrombocytopenia[J].Community Oncology,2011,(05):233-236.
  • 4Gramling MW,Church FC. Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment[J].Thrombosis Research,2010,(05):377-381.
  • 5Bajou K,Peng H,Laug WE. Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis[J].Cancer Cell,2008,(04):324-334.doi:10.1016/j.ccr.2008.08.012.
  • 6Balsara RD,Ploplis VA. Plasminogen activator inhibitor1:the double-edged sword in apoptosis[J].Thrombosis and Haemostasis,2008,(06):1029-1036.
  • 7Su K,Chen F,Yan WM. Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma[J].World Journal of Gastroenterology,2008,(39):5980-5989.doi:10.3748/wjg.14.5980.
  • 8Asanuma K,Wakabayashi H,Okamoto T. The thrombin inhibitor,argatroban,inhibits breast cancer metastasis to bone[J].Breast Cancer,2012.
  • 9Poon RT,Lau CP,Ho JW. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma[J].Clinical Cancer Research,2003,(14):5339-5345.
  • 10Wang X,Wang M,Amarzguioui M. Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice[J].International Journal of Cancer,2004,(06):994-1002.

共引文献55

同被引文献7

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部